Today: 17 April 2026
Subscribe
Browse Category

NASDAQ:CRSR 13 February 2026

Stock Market Today

  • Champion Iron Stock Dips Below 50-Day Moving Average Amid Positive Analyst Ratings
    April 17, 2026, 4:31 AM EDT. Champion Iron Limited's (TSE:CIA) stock price fell below its 50-day moving average of C$5.01, closing at C$4.98 with 232,640 shares traded. Despite this dip, Wall Street analysts maintain optimism, with B. Riley Financial assigning a "strong-buy" rating, Raymond James Financial and Desjardins raising target prices to C$7.00 and rating the stock "outperform" and "buy" respectively. The consensus target price stands at C$6.33. The company reported quarterly earnings per share (EPS) of C$0.12 and revenue of C$472.31 million. Champion Iron holds a market cap of C$2.66 billion and a price-to-earnings ratio of 14.65. It develops iron ore properties in Quebec, focusing mainly on its Mine Site segment.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:31 AM EDT Champion Iron Stock Dips Below 50-Day Moving Average Amid Positive Analyst Ratings April 17, 2026, 4:31 AM EDT. Champion Iron Limited's (TSE:CIA) stock price fell below its 50-day moving average of C$5.01, closing at C$4.98 with 232,640 shares traded. Despite this dip, Wall Street analysts maintain optimism, with B. Riley Financial assigning a "strong-buy" rating, Raymond James Financial and Desjardins raising target prices to C$7.00 and rating the stock "outperform" and "buy" respectively. The consensus target price stands at C$6.33. The company reported quarterly earnings
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop